A Post-Market Clinical Follow-up Investigation to Verify Performance and Safety of Viiral®Nasal Spray in Subjects With Dry Nose Symptoms

NACompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

February 3, 2022

Primary Completion Date

August 16, 2022

Study Completion Date

September 15, 2022

Conditions

Rhinitis Sicca

Interventions

DEVICE

Sialic acid nasal spray

The nasal spray will be self administered twice daily for 8 weeks.

DEVICE

Isotonic Saline Nasal Spray

The nasal spray will be self administered twice daily for 8 weeks.

Trial Locations (2)

Universitetssjukhuset, Avdelning för kliniska prövningar, Örebro

Cordinator Medical Service AB, Linköping

All Listed Sponsors

lead

Viiral Nordic AB

INDUSTRY